Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation

被引：0
|
作者：
Xing, L. Y. [1 ]
Barcella, C. A. [1 ]
Sindet-Pedersen, C. [1 ]
Bonde, A. N. [1 ]
Gislason, G. [1 ]
Olesen, J. B. [1 ]
机构：
[1] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3841
引用
收藏
页码：819 / 819
页数：1
相关论文
共 50 条
  • [31] Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Capodanno, Davide
    Di Maio, Marco
    Greco, Antonio
    Bhatt, Deepak L.
    Gibson, C. Michael
    Goette, Andreas
    Lopes, Renato D.
    Mehran, Roxana
    Vranckx, Pascal
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (16):
  • [32] Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
    Rubboli, Andrea
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 22 - 28
  • [33] Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    van den Dries, Carline J.
    Pajouheshnia, Romin
    van den Ham, Hendrika A.
    Souverein, Patrick
    Moons, Karel G. M.
    Hoes, Arno W.
    Geersing, Geert-Jan
    van Doorn, Sander
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 751 - 761
  • [34] Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation
    Jelonek, Olga
    Gorczyca, Iwona
    Baczek, Michal
    Kosmider, Pawel
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2018, 76 (07) : 1073 - 1080
  • [35] Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study
    Xing, Lucas Yixi
    Barcella, Carlo Alberto
    Sindet-Pedersen, Caroline
    Bonde, Anders Nissen
    Gislason, Gunnar Hilmar
    Olesen, Jonas Bjerring
    THROMBOSIS RESEARCH, 2019, 178 : 101 - 109
  • [36] Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
    Garcia Rodriguez, Luis Alberto
    Martin-Perez, Mar
    Vora, Pareen
    Roberts, Luke
    Balabanova, Yanina
    Brobert, Gunnar
    Fatoba, Samuel
    Suzart-Woischnik, Kiliana
    Schaefer, Bernhard
    Ruigomez, Ana
    BMJ OPEN, 2019, 9 (09):
  • [37] Non-vitamin K antagonist oral anticoagulants in the treatment of coronary and peripheral atherosclerosis
    Witkowski, Adam
    Barylski, Marcin
    Filipiak, Krzysztof J.
    Gierlotka, Marek
    Legutko, Jacek
    Lesiak, Maciej
    Stepinska, Janina
    Wojakowski, Wojciech
    KARDIOLOGIA POLSKA, 2019, 77 (04) : 490 - 504
  • [38] The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
    Patti, Giuseppe
    Cavallari, Ilaria
    Hanon, Olivier
    De Caterina, Raffaele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 118 - 124
  • [39] Clinical Significance of Non-Vitamin K Antagonist Oral Anticoagulants in the Management of Atrial Fibrillation
    Santarpia, Giuseppe
    Curcio, Antonio
    Sibilio, Gerolamo
    Indolfi, Ciro
    CIRCULATION JOURNAL, 2015, 79 (05) : 914 - 923
  • [40] Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation
    Lane, Deirdre A.
    Wood, Kathryn
    CIRCULATION, 2015, 131 (16) : E412 - E415
12345